Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Computer-assisted strategy for drug delivery leads to discovery of polymeric micelle formulations for poorly soluble drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have screened potential hydrophobic drug candidates and found that many hydrophobic drugs can be efficiently solubilized in these POx systems with extremely high drug loading (sometimes approaching or even exceeding 50% by weight drug loading) [116].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The study demonstrated that the computational QSPR modeling could predict the solubility of water-insoluble drugs with a high accuracy of up to 75 %.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, according to Alves et al., POx micelles could solubilize many poorly soluble small molecules with high LC (Table 4) [116].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, solvent selection is a key parameter which is explored in several studies [116, 193, 264]. First of all, both the drug and polymer must be soluble in the selected organic solvent. However, this does not necessarily mean that all good solvents for a polymer-drug system will produce stable, uniform polymeric micelles.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These models were employed for virtual screening of drug libraries, and eight drugs predicted to have either good or poor solubilization in these polymeric micelles were selected. Three putative positives, as well as three putative negative hits, were confirmed experimentally.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Hierarchical Grouping to Optimize an Objective Function
Ward, J. H. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500845 · Cited by 20,598
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
SLOWING, I., VIVEROESCOTO, J., WU, C., & LIN, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.012 · Cited by 2,653
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164 · cited 2×
“Thus, we combined the mixtures out strategy with a fivefold external cross-validation procedure ( 16 , 53 ).”
BackgroundMethodSelf-citationBest Practices for QSAR Model Development, Validation, and Exploitation
Tropsha, A. (2010) · Molecular Informatics · doi:10.1002/minf.201000061 · Cited by 2,024
Self-citationPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Self-citationNanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,313
Self-citationFourches, D., Muratov, E., & Tropsha, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100176x · Cited by 832
Self-citationRational selection of training and test sets for the development of validated QSAR models
Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y.-D., Lee, K.-H., & Tropsha, A. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1025386326946 · Cited by 712 · cited 1×
“5 in this study) and <D> and s are the average and SD, respectively, of all Euclidian distances in the multidimensional descriptor space between each compound and its nearest neighbors for all compounds in the training set (54).”
BackgroundSelf-citationWhen poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Yang, T., Cui, F.-D., Choi, M.-K., Cho, J.-W., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.011 · Cited by 385
Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation
Fourches, D., Muratov, E., & Tropsha, A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00129 · Cited by 294
Self-citationDoubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs
Luxenhofer, R., Schulz, A., Roques, C., Li, S., Bronich, T. K., Batrakova, E. V., Jordan, R., & Kabanov, A. V. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.057 · Cited by 286
Self-citationISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors
Varnek, A., Fourches, D., Horvath, D., Klimchuk, O., Gaudin, C., Vayer, P., Solov'ev, V., Hoonakker, F., Tetko, I., & Marcou, G. (2008) · Current Computer Aided-Drug Design · doi:10.2174/157340908785747465 · Cited by 213
Recent Advances in the Chemistry and Biology of Podophyllotoxins
Yu, X., Che, Z., & Xu, H. (2017) · Chemistry – A European Journal · doi:10.1002/chem.201602472 · Cited by 208
Curation of chemogenomics data
Fourches, D., Muratov, E., & Tropsha, A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1881 · Cited by 192
Self-citationFrederix, P. W. J. M., Patmanidis, I., & Marrink, S. J. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00040a · Cited by 185
The History and Development of Quantitative Structure-Activity Relationships (QSARs)
Dearden, J. C. (2016) · International Journal of Quantitative Structure-Property Relationships · doi:10.4018/ijqspr.2016010101 · Cited by 176
A drug-specific nanocarrier design for efficient anticancer therapy
Shi, C., Guo, D., Xiao, K., Wang, X., Wang, L., & Luo, J. (2015) · Nature Communications · doi:10.1038/ncomms8449 · Cited by 163
Huynh, L., Neale, C., Pomès, R., & Allen, C. J. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.006 · Cited by 159
Hierarchical QSAR technology based on the Simplex representation of molecular structure
Kuz’min, V. Е., Artemenko, A. G., & Muratov, E. N. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9179-6 · Cited by 158
Self-citationWan, X., Min, Y., Bludau, H., Keith, A., Sheiko, S. S., Jordan, R., Wang, A. Z., Sokolsky-Papkov, M., & Kabanov, A. V. (2018) · ACS Nano · doi:10.1021/acsnano.7b07878 · Cited by 158 · cited 1×
“The particle size andmorphology along with the micelle stability and drug release characteristics are important parameters for the pharmacological performance of these drug delivery systems (31).”
BackgroundSelf-citationDrug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s
Schulz, A., Jaksch, S., Schubel, R., Wegener, E., Di, Z., Han, Y., Meister, A., Kressler, J., Kabanov, A. V., Luxenhofer, R., et al. (2014) · ACS Nano · doi:10.1021/nn406388t · Cited by 142 · cited 11×
“ForPTX,KU55933, LDN-57444, and the combination of KU55933/PTX and LDN-57444/ PTX, a mixture of ACN/water (70%/30%, v/v) was used as the mobile phase.”
BackgroundInfluentialSelf-citationExisting and Developing Approaches for QSAR Analysis of Mixtures
Muratov, E. N., Varlamova, E. V., Artemenko, A. G., Полищук, П. Г., & Kuz’min, V. Е. (2012) · Molecular Informatics · doi:10.1002/minf.201100129 · Cited by 139
Self-citationHan, Y., He, Z., Schulz, A., Bronich, T. K., Jordan, R., Luxenhofer, R., & Kabanov, A. V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300159u · Cited by 125
Self-citationAlves, V. M., Muratov, E. N., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.014 · Cited by 120
Self-citationYamamoto, T., Yokoyama, M., Opanasopit, P., Hayama, A., Kawano, K., & Maitani, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.008 · Cited by 114
He, Z., Schulz, A., Wan, X., Seitz, J., Bludau, H., Alakhova, D. Y., Darr, D. B., Perou, C. M., Jordan, R., Ojima, I., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.024 · Cited by 99
Self-citationQuantitative structure - property relationship modeling of remote liposome loading of drugs
Cern, A., Golbraikh, A., Sedykh, A., Tropsha, A., Barenholz, Y., & Goldblum, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.029 · Cited by 98
Self-citationQSAR Modeling and Prediction of Drug–Drug Interactions
Zakharov, A. V., Varlamova, E. V., Lagunin, A. A., Dmitriev, A. V., Muratov, E. N., Fourches, D., Kuz’min, V. Е., Poroikov, V., Tropsha, A., & Nicklaus, M. C. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00762 · Cited by 96
Self-citationAlves, V. M., Muratov, E. N., Zakharov, A. V., MURATOV, N. N., Andrade, C. H., & Tropsha, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.008 · Cited by 79
Self-citationKuz’min, V. Е., Artemenko, A. G., Muratov, E. N., VOLINECKAYA, I., Makarov, V., Riabova, O., Wutzler, P., & Schmidtke, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0704806 · Cited by 73
Self-citationCern, A., Marcus, D., Tropsha, A., Barenholz, Y., & Goldblum, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.015 · Cited by 71
Self-citationOprisiu, I., Varlamova, E., Muratov, E., Artemenko, A., Marcou, G., Polishchuk, P., Kuz'min, V., & Varnek, A. (2012) · Molecular Informatics · doi:10.1002/minf.201200006 · Cited by 69
Self-citationSeo, Y., Schulz, A., Han, Y., He, Z., Bludau, H., Wan, X., Tong, J., Bronich, T. K., Sokolsky, M., Luxenhofer, R., et al. (2015) · Polymers for Advanced Technologies · doi:10.1002/pat.3556 · Cited by 67
Self-citationSolubility enhancement of simvastatin: a review.
Murtaza, G. (2012) · PubMed · Cited by 66
QSAR models of human data can enrich or replace LLNA testing for human skin sensitization
Alves, V. M., Capuzzi, S. J., Muratov, E. N., Braga, R. C., Thornton, T., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2016) · Green Chemistry · doi:10.1039/c6gc01836j · Cited by 65
Self-citationPer Aspera Ad Astra : Application of Simplex Qsar Approach in Antiviral Research
Muratov, E. N., Artemenko, A. G., Varlamova, E. V., Polischuk, P. G., Lozitsky, V. P., Fedchuk, A. S., Lozitska, R. L., Gridina, T. L., Koroleva, L. S., Sil’nikov, V. N., et al. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.194 · Cited by 64
Self-citationPredicting drug loading in PLA-PEG nanoparticles
Meunier, M., Goupil, A., & Lienard, P. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.043 · Cited by 63
Consensus QSAR Modeling of Phosphor‐Containing Chiral AChE Inhibitors
Kuz'min, V. E., Muratov, E. N., Artemenko, A. G., Varlamova, E. V., Gorb, L., Wang, J., & Leszczynski, J. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200860117 · Cited by 52
Self-citationWu, W., Zhang, C., Lin, W., Chen, Q., Guo, X., Qian, Y., & Zhang, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119575 · Cited by 47 · cited 1×
“A recent study reported the development of a series of QSPR models to assess the loading of doxorubicin in polymeric micelles using the genetic function approximation algorithm ( 18 ), but since these models were developed for one drug only, they are not generalizable across multiple drugs.”
MethodPotta, T., Zhen, Z., Grandhi, T. S. P., Christensen, M. D., Ramos, J., Breneman, C. M., & Rege, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.069 · Cited by 44
Rasulev, B., Jabeen, F., Stafslien, S. J., Chisholm, B. J., Bahr, J. A., Ossowski, M., & Boudjouk, P. R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12766 · Cited by 44
Kuramochi, H., Andoh, Y., Yoshii, N., & Okazaki, S. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp906155z · Cited by 43
Computational amphiphilic materials for drug delivery
Thota, N., & Jiang, J. (2015) · Frontiers in Materials · doi:10.3389/fmats.2015.00064 · Cited by 38
Badalkhani‐Khamseh, F., Ebrahim‐Habibi, A., & Hadipour, N. L. (2017) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-017-0091-9 · Cited by 31
Modeling the modified drug release from curved shape drug delivery systems – Dome Matrix®
Caccavo, D., Barba, A. A., D’Amore, M., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.08.016 · Cited by 23
Fragment-based prediction of skin sensitization using recursive partitioning
Lu, J., Zheng, M., Wang, Y., et al. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9472-7 · Cited by 11
Research works printed but not linked: 7
- C. A. Lipinski, Poor aqueous solubility—An industry wide problem in drug discovery. Am. Pharm. Rev. 5, 82–85 (2002).
- T. Heimbach D. Fleisher A. Kaddoumi in Prodrugs V. J. Stella R. T. Borchardt M. J. Hageman R. Oliyai H. Maag J. W. Tilley Eds. (Springer New York 2007) pp. 157–215.
- A. Nag B. Dey Computer-Aided Drug Design and Delivery Systems (McGraw-Hill 2011).
- N. Vityuk, E. Voskresenskaja, V. Kuz’min, The synergism of methods barycentric coordinates and trend-vector for solution—Structure-property tasks. Pattern Recognit. Image Anal. 3, 521–528 (1999).
- G. M. Downs J. M. Barnard in Reviews in Computational Chemistry K. B. Lipkowitz D. B. Boyd Eds. (John Wiley & Sons Inc. 2003) vol. 18 pp. 1–40.
- L. Breiman J. H. Friedman R. A. Olshen C. J. Stone Classification and Regression Trees vol. 19 of Statistics/Probability Series (Chapman and Hall/CRC 1984).
- A. Schulz, Y. Han, Z. He, T. K. Bronich, A. V. Kabanov, R. Luxenhofer, R. Jordan, Poly (2-oxazoline)s: An all-around drug delivery system? Polym. Prepr. 53, 354 (2012).
Cited by
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Self-citationHwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“Wu et al. reported the development of a series of QSPR models to assess the loading of doxorubicin in polymeric micelles using the genetic function approximation algorithm [209,210].”
BackgroundMethodInfluentialSelf-citationHaider, M. S., Lübtow, M. M., Endres, S., Forster, S., Flegler, V. J., Böttcher, B., Aseyev, V., Pöppler, A.-C., & Luxenhofer, R. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22495 · Cited by 100
Metadata
- Authors
- Alves, V. M., Hwang, D., Muratov, E., Sokolsky-Papkov, M., Varlamova, E., Vinod, N., Lim, C., Andrade, C. H., Tropsha, A., & Kabanov, A.
- Affiliations
- Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
- University of North Carolina at Chapel Hill (US)
- Center for Nanotechnology in Drug Delivery, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
- Universidade Federal de Goiás (BR)
- Corresponding author
- Hwang, Duhyeong
- Tropsha, Alexander
- Kabanov, Alexander
- ORCID
- Venue
- Science Advances
- Published
- 2019-06
- Volume
- 5
- Issue
- 6
- Pages
- eaav9784-eaav9784
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6594770
- OpenAlex
- W2956025297
- Cited by
- 56
- References
- 49
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 9 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 1
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (1U01CA207160, GM5105946)
- CNPq (400760/2014-2)
- Carolina Center for Cancer Nanotechnology Excellence (U54CA198999)
- NC TraCS Institute (4DR11404)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- polymeric micelles, poorly water-soluble drugs, drug loading efficiency, loading capacity, virtual screening, drug delivery systems, simvastatin, podophyllotoxin, aqueous solubility enhancement
- MeSH terms
- Cheminformatics, Chemistry, Pharmaceutical, Micelles, Particle Size, Podophyllotoxin, Polymers, Solubility, Water, Drug Delivery Systems, Simvastatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.